RNA Silencing in the Management of Dyslipidemias

PURPOSE OF REVIEW: Remarkable reductions in cardiovascular morbidity and mortality have been achieved in recent decades through the widespread use of ‘small-molecule’ hypolipidaemic drugs such as statins and ezetimibe. An alternative approach is to perturb the production of proteins through ribonucl...

Descripción completa

Detalles Bibliográficos
Autores principales: Henney, Neil C., Banach, Maciej, Penson, Peter E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Nonstatin Drugs (M. Vrablik, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410691/
https://www.ncbi.nlm.nih.gov/pubmed/34468873
http://dx.doi.org/10.1007/s11883-021-00968-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410691/
https://www.ncbi.nlm.nih.gov/pubmed/34468873
http://dx.doi.org/10.1007/s11883-021-00968-7

Ejemplares similares